Revolution Medicines, Inc.

T. Rowe Price Investment Management, Inc. RVMD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

1,300,257

Value ($000)

103,566

Weight

0.1%

2025 Q2 - 2025 Q4 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	103,566	0.1%	1,300,257	12/31/2025
2025 Q3	11/14/2025	223,335	0.1%	4,782,318	9/30/2025
2025 Q2	8/14/2025	172,520	0.1%	4,689,298	6/30/2025